Document is current
Any future updates will be listed below
-
Authors
Streng, Andrea http://orcid.org/0000-0003-2377-7106
Prifert, Christiane
Weissbrich, Benedikt
Sauerbrei, Andreas
Krumbholz, Andi
Schmidt-Ott, Ruprecht
Liese, Johannes G. http://orcid.org/0000-0002-5569-4914
-
Funding
Funding for this research was provided by:
GlaxoSmithKline GmbH & Co.KG (GSK), Munich (EPI-FLU-021)
Universitätsklinikum Würzburg
- License Information
-
More Information
Article History
Received: 10 February 2021
Accepted: 16 December 2021
First Online: 4 January 2022
Declarations
:
: The Ethics Committee of the Medical Faculty, University of Würzburg, approved the study (Reference no. 193/12). All parents or legal guardians provided written informed consent. Only factually anonymized data were analysed at the study coordination centre at the Department of Pediatrics, University Hospital of Würzburg. All methods were performed according to the Declaration of Helsinki and in accordance with all relevant guidelines and regulations.
: Not applicable.
: ASt, JGL and ASa received research grants for studies, lecturing fees or honoraria for expert meetings from GlaxoSmithKline and/or other vaccine manufacturers during previous years. RSO was an employee of GlaxoSmithKline at the time of the study. AK, BW, and CP declare no conflict of interest.
